Activation of HIF-1α in exponentially growing cells via hypoxic stimulation is independent of the Akt/mTOR pathway

Journal of Cellular Physiology

Volumn 218, Issue 1, 2009, Pages 167-174

  Dayan, Frédéric ^a   Bilton, Rebecca L ^a   Laferriére, Julie ^a   Trottier, Eric ^a   Roux, Daniéle ^a   Pouyssegur, Jacques ^a   Mazure, Nathalie M ^a  

^a CENTRE ANTOINE LACASSAGNE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; MAMMALIAN TARGET OF RAPAMYCIN; OLIGOMYCIN; PROTEIN KINASE B; S6 KINASE; PROTEIN KINASE; RAPAMYCIN; SMALL INTERFERING RNA;

ARTICLE; CELL DENSITY; CELL GROWTH; CELL STIMULATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME PHOSPHORYLATION; ENZYME STABILITY; HUMAN; HUMAN CELL; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; ANIMAL; CELL COUNT; CELL HYPOXIA; CELL LINE; CELL PROLIFERATION; CRICETULUS; DRUG ANTAGONISM; GENETICS; HAMSTER; HELA CELL; METABOLISM; PHYSIOLOGY; RNA INTERFERENCE;

ANIMALS; CELL COUNT; CELL HYPOXIA; CELL LINE; CELL PROLIFERATION; CRICETINAE; CRICETULUS; HELA CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; OXYGEN CONSUMPTION; PROTEIN KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIROLIMUS;

EID: 58149157656     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21584     Document Type: Article

References (33)

1. Bernardi R,Guernah I,Jin D,Grisendi S,Alimonti A, Teruya-Feldstein J, Cordon-Cardo C, Simon MC, Rafii S, Pandolfi PP. 2006. PML inhibits HIF-lalpha translation and neoangiogenesis through repression of mTOR. Nature 442:779-785.
2. Berra E, Benizri E, Ginouves A, Volmat V, Roux D, Pouyssegur J. 2003. HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-lalpha in normoxia. EMBO J22:4082-4090.
3. Bilton RL, Booker GW. 2003. The subtle side to hypoxia inducible factor (HIFalpha) regulation. Eur J Biochem 270:791-798.
4. Bruick RK. 2000. Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia. Proc Natl Acad Sci USA 97:9082-9087.
5. Chen C, Okayama H. 1987. High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 7:2745-2752.
6. Fukuda R,Hirota K, Fan F,Jung YD,Ellis LM,Semenza GL.2002.Insulin- likegrowthfactor I induces hypoxia-inducible factor l-mediated vascular endothelial growth factor expression, which is dependenton MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells. J Biol Chem 277:38205-38211.
7. Ginouves A, Ilc K, Macias N, Pouyssegur J, Berra E. 2008. PHDs overactivation during chronic hypoxia "desensitizes" HIFalpha and protects cells from necrosis. Proc Natl Acad Sci USA 105:4745-4750.
8. Gong Y, Agani FH. 2005. Oligomycin inhibits HIF-lalpha expression in hypoxic tumor cells. Am J Physiol Cell Physiol 288:C1023-C1029.
9. Guertin DA, Sabatini DM. 2005. An expanding role for mTOR in cancer. Trends Mol Med 11:353-361.
10. Guertin DA, Sabatini DM. 2007. Defining the role of mTOR in cancer. Cancer Cell 12:9-22.
11. Hagen T, Taylor CT, Lam F, Moncada S. 2003. Redistribution of intracellular oxygen in hypoxia by nitric oxide: Effect on HIFl alpha. Science 302:1975-1978.
12. Hardie DG. 2005. New roles for the LKBl->AMPK pathway. Curr Opin Cell Biol 17:167- 173.
13. Hudson CC,Liu M,Chiang GG,Otterness DM,Loomis DC,Kaper F,Giaccia AJ,Abraham RT. 2002. Regulation of hypoxia-inducible factor lalpha expression and function by the mammalian target of rapamycin. Mol Cell Biol 22:7004-7014.
14. Ivanov S,Liao SY,Ivanova A,Danilkovitch-Miagkova A, Tarasova N,Weirich G,Merrill MJ, Proescholdt MA, Oldfield EH, Lee J, Zavada J, Waheed A, Sly W, Lerman MI, Stanbridge EJ.2001.Expression ofhypoxia-induciblecell-surface transmembrane carbonicanhydrases in human cancer. Am J Pathol 158:905-919.
15. Kallio PJ,Okamoto K, O'Brien S, Carrero P, Makino Y,Tanaka H, Poellinger L. 1998. Signal transduction in hypoxic cells: Inducible nucleartranslocation and recruitment of the CBP/p300 coactivator by the hypoxia-inducible factor-lalpha. EMBO J 17:6573-6586.
16. Kaluz S, Kaluzova M, Chrastina A, Olive PL, Pastorekova S, Pastorek J, Lerman MI, Stanbridge EJ. 2002. Lowered oxygen tension induces expression of the hypoxia marker MN/carbonic anhydrase IX in the absence of hypoxia-inducible factor I alpha stabilization: A role for phosphatidylinositol 3'-kinase. Cancer Res 62:4469-4477.
17. Kaluz S, Kaluzova M, Stanbridge EJ. 2006. The role ofextracellular signal-regulated protein kinase in transcriptional regulation of the hypoxia marker carbonic anhydrase IX. J Cell Biochem 97:207-216.
18. Kopacek J, Barathova M,Dequiedt F, Sepelakova J, Kettmann R, Pastorek J, Pastorekova S. 2005. MAPK pathway contributes to density- and hypoxia-induced expression ofthe tumor-associated carbonic anhydrase IX. Biochim Biophys Acta 1729:41-49.
19. Kwiatkowski DJ,Manning BD.2005.Tuberoussclerosis: AGAPatthecrossroadsofmultiple signaling pathways. Hum Mol Genet 14(Spec No. 2): R251-R258.
20. Laughner E, Taghavi P, Chiles K, Mahon PC, Semenza GL. 2001. HER2 (neu) signaling increases the rate of hypoxia-inducible factor lalpha (HIF-lalpha) synthesis: Novel mechanism for HIF-l-mediated vascular endothelial growth factor expression. Mol Cell Biol 21:3995-4004.
21. Mazure NM,Brahimi-Horn MC,Berta MA,Benizri E,Bilton RL,Dayan F,Ginouves A,Berra E, Pouyssegur J. 2004. HIF-l: Master and commander of the hypoxic world. A pharmacological approach to its regulation by siRNAs. Biochem Pharmacol 68:97l-980.
22. Mohan S, Burk RD. 2003. von Hippel-Lindau protein complex is regulated by cell density. Oncogene 22:5270-5280.
23. Paltoglou SM,Roberts BJ.2005.Roleofthevon Hippel-Lindau tumoursuppressorprotein in the regulation of HIF-l alpha and its oxygen-regulated transactivation domains athigh cell density. Oncogene 24:3830-3835.
24. Pouyssegur J, Franchi A, Pages G. 200l. pHi, aerobic glycolysis and vascular endothelial growth factor in tumour growth. Novartis Found Symp 240:186-196.
25. Pouyssegur J, Dayan F, Mazure NM. 2006. Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 441:437-443.
26. Richard DE, Berra E, Gothie E, Roux D, Pouyssegur J. l999. p42/p44 mitogen-activated protein kinases phosphorylate hypoxia- inducible factor lalpha (HIF-lalpha) and enhance the transcriptional activity ofHIF-l. J Biol Chem 274:32631-32637.
27. Semenza GL. 2001. HIF-l and mechanisms of hypoxia sensing. Curr Opin Cell Biol 13:167-171.
28. Sheta EA, Trout H, Gildea JJ, Harding MA, Theodorescu D. 2001. Cell density mediated pericellular hypoxia leads to induction of HIF-lalpha via nitric oxide and Ras/MAP kinase mediated signaling pathways. Oncogene 20:7624-7634.
29. Thomas GV,Tran C,Mellinghoff IK,Welsbie DS,Chan E,Fueger B,Czernin J,Sawyers CL. 2006. Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer. Nat Med 12:122-127.
30. Treins C, Giorgetti-Peraldi S, Murdaca J, Semenza GL, Van Obberghen E. 2002. Insulin stimulates hypoxia-inducible factor l through a phosphatidylinositol 3-kinase/target of rapamycin-dependent signaling pathway. J Biol Chem 277:27975-27981.
31. van de Wetering M, Oving I, Muncan V, Pon Fong MT, Brantjes H, van Leenen D, Holstege FC, Brummelkamp TR, Agami R, Clevers H. 2003. Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector. EMBO Rep 4:609-615.
32. Wenger RH,Stiehl DP,Camenisch G.2005.Integration of oxygen signaling at the consensus HRE. Sci STKE 306:re12.
33. Wiesener MS, Turley H, Allen WE, Willam C, Eckardt KU, Talks KL, Wood SM, Gatter KC, Harris AL, Pugh CW, Ratcliffe PJ, Maxwell PH. l998. Induction ofendothelial PAS domain protein-l by hypoxia: Characterization and comparison with hypoxia-inducible factor-l alpha. Blood 92:2260-2268.